Results 31 to 40 of about 20,556 (211)

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study

open access: yesAnnals of Clinical Microbiology and Antimicrobials, 2010
Background The frequency of primary resistance to antibiotics in H. pylori isolates is increasing worldwide. In Tunisia, there are limited data regarding the pattern of H. pylori antibiotic primary resistance. Aim To evaluate the primary resistance of H.
Ben Mansour Khansa   +21 more
doaj   +1 more source

Trends in Helicobacter pylori resistance to clarithromycin: from phenotypic to genomic approaches [PDF]

open access: yes, 2022
For a long time Helicobacter pylori infections have been treated using the macrolide antibiotic, clarithromycin. Clarithromycin resistance is increasing worldwide and is the most common cause of H. pylori treatment failure.
Vale, Filipa   +4 more
core   +2 more sources

Characteristics of Helicobacter pylori antibiotic resistance: data from four different populations

open access: yesAntimicrobial Resistance and Infection Control, 2019
Aims To describe the characteristics of Helicobacter pylori (H. pylori) antibiotic resistance in clinical isolates from four populations. Methods In total, 1463 H. pylori strains were examined for antibiotic resistance.
Dong-sheng Liu   +7 more
doaj   +1 more source

Assessment of antimycobacterial activities of pure compounds extracted from Thai medicinal plants against clarithromycin-resistant Mycobacterium abscessus [PDF]

open access: yesPeerJ, 2021
Background Infection with Mycobacterium abscessus is usually chronic and is associated with clarithromycin resistance. Increasing drug resistance is a major public-health problem and has led to the search for new antimycobacterial agents.
Auttawit Sirichoat   +6 more
doaj   +2 more sources

Detection by Real-Time PCR of Helicobacter pylori and Clarithromycin Resistance Compared to Histology on Gastric Biopsies. [PDF]

open access: yesMicroorganisms
The global rise in Helicobacter pylori (H. pylori)-related gastric complications is largely driven by increasing antimicrobial resistance and treatment failures. As a result, accurate diagnosis followed by effective treatment is crucial.
Pittie G   +5 more
europepmc   +2 more sources

Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2007
Recently, there has been a decrease in the eradication rate of Helicobacter pylori due to the increase in antibiotic resistance of this bacterium. Plaunotol, a cytoprotective anti-ulcer agent, exhibits antibacterial activity against H. pylori. The purpose of the present study was to investigate the effect of plaunotol in combination with clarithromycin
Makoto, Sasaki   +16 more
openaire   +2 more sources

Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole–amoxicillin–clarithromycin therapy [PDF]

open access: yesAlimentary Pharmacology & Therapeutics, 2001
Background: Helicobacter pylori resistance to clarithromycin is relatively frequent in France and is assumed to be the main cause of failure of the proton pump inhibitor–amoxicillin–clarithromycin (proton pump inhibitor–AC) therapy, which is the first‐line regimen in France.Aim:To determine the respective effects of clarithromycin primary and secondary
J, Tankovic   +4 more
openaire   +2 more sources

Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
The increasing antibiotic resistance of Helicobacter pylori infection is a globally urging problem. To investigate the H. pylori resistance situation in Nanjing, China, we enrolled patients in Nanjing First Hospital from January 2018 to May 2021.
Zongdan Jiang   +6 more
doaj   +1 more source

Clarithromycin-Resistant Mycobacterium avium Is Still Susceptible to Treatment with Clarithromycin and Is Virulent in Mice [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2000
ABSTRACT Resistance to clarithromycin in breakthrough Mycobacterium avium complex (MAC) isolates typically occurs 3 to 4 months after the initiation of monotherapy in bacteremic AIDS patients. It has been suggested that continuation of clarithromycin therapy still results in clinical and microbiological ...
L E, Bermudez   +4 more
openaire   +2 more sources

Anti-Helicobacter pylori Effects of Propolis Ethanol Extract on Clarithromycin and Metronidazole Resistant Strains [PDF]

open access: yes, 2020
Antimicrobial resistance for Helicobacter pylori infection still become problem in Indonesia especially for metronidazole and clarithromycin resistance that is commonly used in the national regiment therapy. Finding a new antimicrobial agent against this
Ari Fahrial Syam   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy